Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about atai Life Sciences
Recent news which mentions atai Life Sciences
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
November 13, 2024
Tickers
ATAI
DMT
MDMA
NEWS
Tags
Ibogaine
Benzinga
Psychedelics
From
Benzinga
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
Tickers
ATAI
ENVB
NEWS
Tags
Joseph Tucker
ATAI
Cannabis
From
Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
Tickers
ATAI
CMPS
DMT
MBIO
Tags
Cannabis
Lykos Therapeutics
CMPS
From
Benzinga
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
Tickers
ABBV
ATAI
CMPS
COMP
Tags
COMP
ABBV
Biopharma
From
Benzinga
Atai's DMT Depression Drug Shows Promise, Prepares For Phase II Trial And Future Collaboration With Pharma Giant
August 14, 2024
Tickers
ATAI
Tags
ATAI Life Sciences
Health Care
treatment/resistant depression
From
Benzinga
atai Life Sciences advances VLS-01 for treatment-resistant depression
March 12, 2024
Tags
XNAS:ATAI
atai Life Sciences
From
TheNewswire.com - RSS (Media)
atai's Phase 1 Synthetic DMT-Based Drug Clinical Trial Begins Patient Dosing
October 05, 2022
Tickers
ATAI
Tags
ATAI
DMT Clinical Trial
Markets
From
Benzinga
Atai Life Sciences: Capital Raise, Share Options, Cathy Wood And More On Biotech Psychedelics Leader
July 07, 2022
Tickers
ATAI
Tags
Cathy Wood
Florian Brand
News
From
Benzinga
ATAI Life Sciences Present A "New Recipe For Success" At The Psychedelic Capital Conference
April 29, 2022
Tickers
ATAI
Tags
Market News
Markets
ATAI
From
Benzinga
atai Life Sciences Announces Fourth Quarter and Full Year 2021 Financial Results
March 30, 2022
Tickers
ATAI
CMPS
IGXT
Tags
IGXT
IntelGenx
ATAI Life Sciences
From
Benzinga
Are Psychedelics Starting to Emerge as Legitimate Therapies?
January 19, 2022
Tickers
DMT
MDMA
Tags
Doc Gumshoe
MDMA
MindMed (MMED/NEO MMEDF)
From
Stock Gumshoe
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
Tickers
ATAI
NVMDF
Tags
Small Cap
Regulations
Topics
From
Benzinga
New York's Horizons Psychedelic Conference Highlights Big Donations In The Growing Industry
December 07, 2021
Tickers
ATAI
SPCE
TSLA
Tags
Health Care
ATAI Life Sciences
News
From
Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
November 29, 2021
Tickers
ATAI
CMPS
Tags
General
Benzinga
Compass Pathways
From
Benzinga
This Psychedelics Stock Was Up More Than 20% Last Week, Outperforming Tesla, Nvidia and GameStop
November 02, 2021
Tickers
ATAI
GME
NVDA
TSLA
Tags
Small Business
General
Benzinga
From
Benzinga
Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics
September 17, 2021
Tickers
TC
Tags
Columbia University
ela madej
depression
From
TechCrunch
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.